tirzepatide surpass trials Efficacy and safety of monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial SURPASS-CVOT Published: Large Trial Confirms

Key Benefits of Microdosing GLP-1: Gentle on the stomach : Starting with smaller doses reduces the chances of side effects for people new to GLP-1 drugs

This science-backed approach makes MEDVi not merely a telehealth provider, but a pioneer in evidence-based, physician-guided GLP-1 weight management for the modern era

Cheng, X., Patel, S., & Nguyen, T

Telomere Biology This tetrapeptide has gained significant attention in longevity and anti-aging research based on findings suggesting it can influence telomere length, activate telomerase in somatic cells, normalize circadian rhythms, and potentially extend lifespan in animal models

TEAE = treatment-emergent adverse event

A., Seeley, R